Inventor · disambiguated record
Matthew P. Bourbeau
Also filed as: BOURBEAU MATTHEW P · BOURBEAU MATTHEW PAUL
25 granted patents·11 pending applications·181 citations·filing 2005–2024
94Inventor score
Top patents by PatentIndex Score
36 records- 0194US7897619B2Heterocyclic modulators of PKBAMGEN INC·Filed 2008·Granted Mar 1, 2011·42 cites·41 claims
- 0294US7514566B2Thiazole compounds and methods of useAMGEN INC·Filed 2007·Granted Apr 7, 2009·38 cites·48 claims
- 0394US7354944B2Thiadiazole compounds and methods of useAMGEN INC·Filed 2005·Granted Apr 8, 2008·38 cites·8 claims
- 0493US7919504B2Thiadiazole modulators of PKBAMGEN INC·Filed 2008·Granted Apr 5, 2011·30 cites·16 claims
- 0591US8053438B2Pyrazine compounds as phosphodiesterase 10 inhibitorsAMGEN INC·Filed 2009·Granted Nov 8, 2011·13 cites·24 claims
- 0689US12054476B2KIF18A inhibitorsAMGEN INC·Filed 2021·Granted Aug 6, 2024·1 cites·31 claims
- 0787US12448396B2Methods of using heterocyclic compounds as Delta-5 Desaturase inhibitorsAMGEN INC·Filed 2022·Granted Oct 21, 2025·1 cites·59 claims
- 0887US11236069B2KIF18A inhibitorsAMGEN INC·Filed 2019·Granted Feb 1, 2022·4 cites·25 claims
- 0985US12509442B2KIF18A inhibitorsAMGEN INC·Filed 2024·Granted Dec 30, 2025·0 cites·32 claims
- 1084US11845760B2PRMT5 inhibitorsAMGEN INC·Filed 2021·Granted Dec 19, 2023·1 cites·46 claims
- 1183US8247418B2Pyrazine compounds as phosphodiesterase 10 inhibitorsALLEN JENNIFER R·Filed 2011·Granted Aug 21, 2012·5 cites·11 claims
- 1280US8329700B2Pyrazine compounds as phosphodiesterase 10 inhibitorsALLEN JENNIFER R·Filed 2011·Granted Dec 11, 2012·4 cites·85 claims
- 1375US12459932B2KIF18A inhibitorsAMGEN INC·Filed 2019·Granted Nov 4, 2025·1 cites·34 claims
- 1475US12441736B2KIF18A inhibitorsAMGEN INC·Filed 2019·Granted Oct 14, 2025·1 cites·31 claims
- 1571US8084479B2Thiazole compounds and methods of useZENG QINGPING·Filed 2009·Granted Dec 27, 2011·1 cites·20 claims
- 1669US9550762B2Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2015·Granted Jan 24, 2017·1 cites·95 claims
- 1769US2024092794A1Novel prmt5 inhibitorsAMGEN INC·Filed 2023·Application pending·0 cites
- 1865US2024409557A15,6-fused and 6,6-fused bicyclic alcohols and ethers and compositions for use as 15-prostaglandin dehydrogenase modulatorsAMGEN INC·Filed 2024·Application pending·0 cites
- 1963US2021221824A1Heterocyclic compounds as delta-5 desaturase inhibitors and methods of useAMGEN INC·Filed 2021·Application pending·0 cites
- 2062US11512097B2Heterocyclic compounds as Delta-5 desaturase inhibitors and methods of useAMGEN INC·Filed 2020·Granted Nov 29, 2022·0 cites·38 claims
- 2157US2012277209A1Pyrazine compounds as phosphodiesterase 10 inhibitorsALLEN JENNIFER R·Filed 2012·Application pending·0 cites
- 2254US2024124442A1Tricyclic-amido-bicyclic prmt5 inhibitorsAMGEN INC·Filed 2022·Application pending·0 cites
- 2352US12473289B2Heterocyclic compounds as delta-5 desaturase inhibitors and methods of useAMGEN INC·Filed 2020·Granted Nov 18, 2025·0 cites·10 claims
- 2452US2023159510A1Novel prmt5 inhibitorsAMGEN INC·Filed 2021·Application pending·0 cites
- 2552US2024101570A1Tricyclic carboxamide derivatives as prmt5 inhibitorsAMGEN INC·Filed 2021·Application pending·0 cites
- 2651US2022289724A1Kif18a inhibitorsAMGEN INC·Filed 2020·Application pending·0 cites
- 2751US2022281843A1Kif18a inhibitorsAMGEN INC·Filed 2020·Application pending·0 cites
- 2848US12441705B2KIF18A inhibitorsAMGEN INC·Filed 2019·Granted Oct 14, 2025·0 cites·34 claims
- 2948US11548903B2Bicyclic thiazine and oxazine derivatives as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2017·Granted Jan 10, 2023·0 cites·29 claims
- 3048US10889581B2Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2017·Granted Jan 12, 2021·0 cites·21 claims
- 3146US10947223B2Substituted oxazines as beta-secretase inhibitorsAMGEN INC·Filed 2017·Granted Mar 16, 2021·0 cites·26 claims
- 3246US2017267673A1Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2016·Application pending·0 cites
- 3345US11021493B21,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2017·Granted Jun 1, 2021·0 cites·33 claims
- 3444US10889579B2Thiazine derivatives as β-secretase inhibitors and methods of useAMGEN INC·Filed 2017·Granted Jan 12, 2021·0 cites·20 claims
- 3538US10246429B2Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2016·Granted Apr 2, 2019·0 cites·54 claims
- 3637US2011263647A1Fluoroisoquinoline substituted thiazole compounds and methods of useAMGEN INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew P. Bourbeau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →